Hopefully, this will drive policy changes, lower prices, and expand access, while also marking an important shift: seeing obesity as a disease that deserves proactive, evidence-based treatment. While semaglutide is the most prominent of them all, dulaglutide and liraglutide, as well as the dual GLP-1/GIP agonist GIP plays a similar role to GLP-1 tirzepatide, present in Lillys Mounjaro and Zepbound, also join the list as therapeutic alternatives. Even biosimilars, which are drugs that are highly similar to biologics with regard to their quality, safety, and efficacy, were listed
Not only does Ozempic help Type II diabetics combat their insulin deficiency, but its also been proven highly effective at helping some individuals lose significant amounts of weight
I do add a packet of chick-fil-a sauce because that shit is magical
Also, background references (where appropriate) include the keywords: estrogens, SERMs, skin aging, microbiome, isoflavonoids, phytoestrogens, phytochemicals, polyphenols, and/or combinations (without a year-limit range for searching these topics)